Anlon Healthcare Ltd

BSE: 544497

total announcements

544497.BO · 15 min delayed

BSEResultResults22h ago

We have attached herewith financial results for the quarter ended June 30, 2026. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The company has also authorized a share swap arrangement with shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited to acquire a majority stake in these entities.

We have attached herewith outcome of Board Meeting to consider and approve the Financial Results for the quarter ended June 30, 2026. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has announced the outcome of its Board Meeting, where the Board considered and approved the unaudited financial results for the quarter ended June 30, 2026, and also authorized the Chairman & Managing Director and/or Whole Time Director to enter into a share swap arrangement with the shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited.

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve 1. To consider and approve ....

Anlon Healthcare Ltd has scheduled a board meeting on July 30, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and to authorize a share swap arrangement with shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited.